瑞普生物
(300119)
| 流通市值：53.15亿 | | | 总市值：74.14亿 |
| 流通股本：3.34亿 | | | 总股本：4.66亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 335,400,774.94 | 388,157,967.06 | 292,103,165.54 | 326,287,013.13 |
| 应收票据及应收账款 | 955,689,671.03 | 884,371,242.83 | 791,716,113.17 | 739,191,273.92 |
| 其中：应收票据 | 12,808,002.77 | 14,797,012.02 | 13,943,198.31 | 9,426,556.55 |
| 应收账款 | 942,881,668.26 | 869,574,230.81 | 777,772,914.86 | 729,764,717.37 |
| 应收款项融资 | 3,957,366.4 | 1,199,980 | 3,706,060 | 8,304,571.76 |
| 预付款项 | 31,506,353.68 | 28,647,374.52 | 23,849,019.29 | 35,465,523.39 |
| 其他应收款合计 | 46,558,192.72 | 51,263,445.05 | 49,730,479.77 | 55,438,644.6 |
| 其中:应收利息 | 700,138.82 | 612,206.95 | 627,812.39 | 458,995.15 |
| 存货 | 389,931,740.06 | 386,341,371.21 | 403,943,604.99 | 402,264,003.91 |
| 其他流动资产 | 216,881,122 | 174,484,417.57 | 57,247,510.57 | 70,931,490.81 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,263,327,707.08 | 3,038,546,011.31 | 2,926,085,762.65 | 2,983,122,833.86 |
| 非流动资产: | | | | |
| 长期股权投资 | 453,445,601.11 | 445,523,133.41 | 470,802,149.27 | 402,109,504.2 |
| 其他非流动金融资产 | 622,875,093.53 | 512,105,259.2 | 512,200,903.64 | 502,248,725.86 |
| 投资性房地产 | 41,456,028.66 | 42,454,255.73 | 43,452,482.82 | 44,450,709.89 |
| 固定资产 | 1,547,429,333.23 | 1,254,450,345.31 | 1,242,987,710.4 | 1,167,250,423.57 |
| 在建工程 | 87,830,567.96 | 374,594,139.24 | 360,712,746.47 | 403,939,589.55 |
| 使用权资产 | 18,514,773.51 | 20,517,980.85 | 58,246,064.45 | 37,644,133.03 |
| 无形资产 | 238,339,326.62 | 257,342,221.65 | 257,315,324.34 | 256,029,696.79 |
| 开发支出 | 180,366,955.61 | 164,919,896.9 | 154,497,247.73 | 146,908,312.47 |
| 商誉 | 67,802,743.36 | 67,802,743.36 | 67,802,743.36 | 67,802,743.36 |
| 长期待摊费用 | 406,117.55 | 491,261.56 | 631,749.93 | 799,910.52 |
| 递延所得税资产 | 12,262,839.72 | 12,962,782.99 | 10,775,328.16 | 9,884,408.36 |
| 其他非流动资产 | 61,884,413.14 | 26,793,009.72 | 7,077,621.56 | 7,700,658.84 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,332,613,794 | 3,179,957,029.92 | 3,186,502,072.13 | 3,046,768,816.44 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 6,595,941,501.08 | 6,218,503,041.23 | 6,112,587,834.78 | 6,029,891,650.3 |
| 流动负债: | | | | |
| 短期借款 | 533,832,311.73 | 339,923,961.06 | 426,224,533.31 | 497,583,608.2 |
| 应付票据及应付账款 | 561,973,835.63 | 465,813,127.45 | 468,236,310.82 | 447,479,015.2 |
| 其中：应付票据 | 189,591,484.8 | 134,688,631 | 136,018,545.5 | 117,459,345.5 |
| 应付账款 | 372,382,350.83 | 331,124,496.45 | 332,217,765.32 | 330,019,669.7 |
| 预收款项 | 84,000.88 | 435,584.35 | 112,965.19 | 78,767.65 |
| 合同负债 | 16,459,352.1 | 12,832,023.43 | 31,879,954.8 | 22,400,626.84 |
| 应付职工薪酬 | 60,066,462.78 | 36,393,048.31 | 32,843,109.25 | 25,695,942.98 |
| 应交税费 | 30,121,543.63 | 30,528,577.42 | 22,118,300.56 | 29,608,814.65 |
| 其他应付款合计 | 107,612,345.11 | 217,411,155.88 | 87,911,938.8 | 107,580,010.35 |
| 应付股利 | 12,344,000 | - | 3,492,000 | 764,000 |
| 一年内到期的非流动负债 | 22,269,214.27 | 28,091,871.74 | 21,828,364.85 | 12,227,995.03 |
| 其他流动负债 | 12,486,327.24 | 8,955,233.21 | 10,316,780.86 | 5,192,384.85 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,344,905,393.37 | 1,140,384,582.85 | 1,101,472,258.44 | 1,147,847,165.75 |
| 非流动负债: | | | | |
| 长期借款 | 307,114,925.87 | 307,472,205.87 | 335,086,391.7 | 187,821,524.22 |
| 租赁负债 | 8,858,502.76 | 8,815,754.33 | 12,731,753.89 | 902,870.36 |
| 递延收益 | 53,543,906.4 | 53,049,145.29 | 58,363,807.64 | 50,374,240.54 |
| 递延所得税负债 | 76,632,845.01 | 62,985,532.34 | 62,303,902.7 | 57,331,768.94 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 446,150,180.04 | 432,322,637.83 | 468,485,855.93 | 296,430,404.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,791,055,573.41 | 1,572,707,220.68 | 1,569,958,114.37 | 1,444,277,569.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 466,276,186 | 466,276,186 | 468,018,786 | 468,018,786 |
| 资本公积 | 2,193,668,540.36 | 2,192,558,830.65 | 2,206,067,531.47 | 2,204,850,033.13 |
| 减:库存股 | 69,084,121.08 | 24,162,219.55 | 41,152,569.55 | 41,152,569.55 |
| 盈余公积 | 232,291,974.82 | 195,638,234.69 | 195,638,234.69 | 195,638,234.69 |
| 未分配利润 | 1,673,151,533.16 | 1,530,561,202.14 | 1,435,134,342.76 | 1,476,959,616.28 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,496,304,113.26 | 4,360,872,233.93 | 4,263,706,325.37 | 4,304,314,100.55 |
| 少数股东权益 | 308,581,814.41 | 284,923,586.62 | 278,923,395.04 | 281,299,979.94 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,804,885,927.67 | 4,645,795,820.55 | 4,542,629,720.41 | 4,585,614,080.49 |
| 负债和股东权益合计 | 6,595,941,501.08 | 6,218,503,041.23 | 6,112,587,834.78 | 6,029,891,650.3 |
| 公告日期 | 2024-03-30 | 2023-10-26 | 2023-08-26 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |